Hykes Andrew's Form 4 filing
Inari Medical, Inc. (NARI) · filed Jul 6, 2022
- Accession no.
- 0001127602-22-019006
- Filed
- Jul 6, 2022
- Trade date
- Jul 1-5, 2022
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $351.6K. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hykes AndrewCIK 0001806431 | Officer (Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2022 | Common Stock | FTax withholdingDisposed | −347 | $68.66 | −$23,825.02 | 146,637 | Direct | |
| Jul 1, 2022 | Common Stock | FTax withholdingDisposed | −646 | $68.66 | −$44,354.36 | 145,991 | Direct | |
| Jul 5, 2022 | Common Stock | SSaleDisposed | −5,000 | $70.31F4 | −$351,550 | 140,991 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F4
This transaction was executed in multiple trades at prices ranging from $70.00 to $70.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.